Daniel Swineford, DPM
Podiatrist · Franklin, MANPI 1922193762
Payments from drug & device makers
What this record shows
This record is dominated by other: $3,017 of the $4,573 with a category attached, or 66.0%. Integra Lifesciences Corporation accounts for 68.8% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $3,020, more than ten times the $26 reported in 2020.
Across 52 payments — averaging $87.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$3K
- Arthrex$462
- Mimedx Group, Inc.$343
- Smith+Nephew$263
- Paratek Pharmaceuticals, Inc.$87
- Kairos Surgical Inc$63
- plus $210 from 8 others
What the payments were for
- Travel & lodging$4249%
- Food & beverage$1,11924%
- Education$120%
- Other$3,01766%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 10 | $3,144 |
| Arthrex | 4 | $462 |
| Mimedx Group, Inc. | 8 | $343 |
| Smith+Nephew | 14 | $263 |
| Paratek Pharmaceuticals, Inc. | 5 | $87 |
| Kairos Surgical Inc | 1 | $63 |
| Treace Medical Concepts, Inc. | 2 | $59 |
| Zimmer Biomet | 2 | $47 |
| Bone Support Inc. | 1 | $27 |
| Vertex | 1 | $20 |
| Orthofix Medical, Inc. | 1 | $20 |
| Averitas Pharma Inc. | 1 | $14 |
| Osteomed LLC | 1 | $12 |
| Bioventus LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMNIOEXCEL PLUS$2,442
- ACell$512
How this compares
$4,573 in reported general payments places this provider in the 85th percentile of 179 podiatrist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 30 | $1,099 |
| Gabapentin | 48 | $523 |
| Diclofenac Sodium | 28 | $134 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $85 |
| Meloxicam | 12 | $44 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Franklin
- Pasquale CancelliereSomerville$374K
- Michael TheodoulouSomerville$210K
- Sara Rose-SauldWaltham$92K
- Jonathan KaplanWellesley$56K
- Thanh DinhBoston$48K
- Melissa RicciMilton$46K
- Jeffrey PantanoMilton$46K
- Barry RosenblumBoston$43K
- Louis DecaroWest Hatfield$19K
- Daren BergmanFramingham$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.